BridgeMD
New treatment option for Allergic Rhinitis
Official title Comparison of the Effects for Lightening the Shiners Among Different Treatments for Rhinitis
ClinicalTrials.gov ID: NCT05348148
What this study is testing
What is Oral Levocetirizine?
Oral Levocetirizine is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for allergic rhinitis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Background: Shiners are caused when blood and other fluids accumulate in the infraorbital groove. It develops resulting from lots of problems.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 65
You may be able to join if
- Clinical diagnosis of moderate to severe rhinitis, either allergic rhinitis or non-allergic rhinitis.
You likely can't join if
- Chronic rhinosinusitis
- Trauma to the forehead or nose
- Face surgery
- Malignancy
- Pregnancy
- Respiratory tract infections within a week before beginning the study
See the full eligibility criteria
- Clinical diagnosis of moderate to severe rhinitis, either allergic rhinitis or non-allergic rhinitis.
- Chronic rhinosinusitis
- Trauma to the forehead or nose
- Face surgery
- Malignancy
- Pregnancy
- Respiratory tract infections within a week before beginning the study
- Usage of medications for rhinitis within a week before beginning the study
The study team makes the final eligibility decision.
Where it's taking place
- Luodong, Yilan, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Luodong, Yilan, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.